Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies for metabolic and endocrine disorders, including obesity and liver disease.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 42 | Holds (flat) | 170 | $5,532 | 0.0% |
| Bridgewater | 55 | Trimmed -31% | 71,229 | $2,317,792 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.